Direct evidence of oxidative damage in acute and chronic phases of experimental colitis in rats

Digestive Diseases and Sciences

Volumn 41, Issue 6, 1996, Pages 1204-1211

  Loguercio, Carmela ^a,b   D'Argenio, Giuseppe ^a   Delle Cave, Massimo ^a   Cosenza, Vittorio ^a   Della Valle, Nicola ^a   Mazzacca, Gabriele ^a   Blanco, Camillo Del Vecchio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE   (Italy)

Author keywords

Experimental colitis; Free radicals; Glutathione; Lipoperoxidation; Superoxide dismutase

Indexed keywords

FREE RADICAL; GLUTATHIONE; SUPEROXIDE DISMUTASE;

ARTICLE; COLITIS; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ACUTE DISEASE; ANIMALS; CHRONIC DISEASE; COLITIS; COLON; ETHANOL; GLUTATHIONE; INTESTINAL MUCOSA; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; TRINITROBENZENESULFONIC ACID;

EID: 0029681588     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02088238     Document Type: Article

References (34)

1. Parks DA, Bulkley GB, Granger DN: Role of oxygen-derived free radicals in digestive tract disease. Surgery 94(3):415-422, 1983
2. Keshavarzian A, Morgan G, Sedghi S, Gordon JH, Doria M: Role of reactive oxygen metabolites in experimental colitis, Gut 31:786-790, 1990
3. Van Der Vliet A, Bast A: Role of reactive oxygen species in intestinal diseases. Free Radic Biol Med 12:499-513, 1992
4. Sedghi S, Fields JZ, Urban G, Durkin M, Winship D, Fretland D, Olyaee M, Keshavarzian A: Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis. Gut 34:1191-1197, 1993
5. Grisham MB: Oxidants and free radicals in inflammatory bowel disease. Lancet 344:859-861, 1994
6. Baker SS, Campbell CL: Rat enterocyte injury oxygen-dependent processes. Gastroenterology 101:716-720, 1991
7. Salim AS: Role of oxygen-derived free radical scavengers in the management of recurrent attacks of ulcerative colitis: A new approach. J Lab Clin Med 119(6):710-717, 1992
8. Siems GW, Grune T, Werner A, Gerber G, Buntrock P, Schneider W: Protective influence of oxypurinol on the trinitrobenzene sulfonic acid (TNB) model of inflammatory bowel disease in rats. Cell Mol Biol 38(2):189-199, 1992
9. Simmonds NJ, Rampton DS: Inflammatory bowel disease-a radical view. Gut 34:865-868, 1993
10. Markowitz MM, Rozen P, Pero RW, Tobi M, Miller DG: Hydrogen peroxide induced adenosine diphosphate ribosyl transferase (ADPRT) response in patients with inflammatory bowel disease. Gut 29:1680-1686, 1988
11. Grisham MB, MacDermott RP, Deitch EA: Oxidant defense mechanisms in the human colon. Inflammation 14(6):669-680, 1990
12. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace J: Hapten-induced model of chronic inflammation and ulceration in rat colon. Gastroenterology 96:795-803, 1989
13. D'Argenio G, Sorrentini I, Cosenza V, Gatto A, Iovino P, D'Armiento FP, Baldassarre F, Mazzacca G: Serum and tissue transglutaminase correlates with the severity of inflammation in induced colitis in the rat. Scand J Gastoenterol 27:111-114, 1992
14. Hirata K, Hiranuma K, Hirano H, Osaka T, Itoh H, Ohsato K: The healing process of chronic colitis in rats, induced by 2,4,6-trinitrobenzene sulfonic acid, with special reference to the role of fibronectin. Scand J Gastroenterol 29:624-629, 1994
15. Grisham MB, Volkmer C, Tso P, Yamada T: Metabolism of trinitrobenzene sulfonic acid by the rat colon produces reactive oxygen species. Gastroenterology 101:540-547, 1991
16. Meister A: Functions of glutathione. In A Larsson, et al (eds). Function of Glutathione. New York, Raven Press, 1983
17. Verspaget HW, Pena AS, Weterman IT, Lamers CBHN: Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content. Gut 29:223-228, 1988
18. Mulder TPJ, Verspaget HW, Janssens AR, de Bruin PAF, Pena AS, Lamers CBHW: Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease. Gut 32:1146-1150, 1991
19. Inaucn W, Bilzer W, Rowedder E, Halter F, Lauterburg BH: Decreased glutathione (GSH) in colonic mucosa of patients with inflammatory bowel disease (IBD): Mediated by oxygen free radicals? Gastroenterology 101(3):A199, 1988
20. Reynolds PD, Hunter JO: Glutathione is depleted in active Crohn's disease. 3rd United European Gastroenterologic Week, Oslo, A116:1356, 1994
21. Gross V, Arndt H, Andus T, Palitzsch KD, Scholmerich J: Free radicals in inflammatory bowel diseases. Pathophysiology and therapeutic implications. Hepato-Gastroenterol 41:320-327, 1994
22. Newton GL, Dorian R, Fahey RC: Analysis of biological thiols: Derivatization with monobromobimane and separation by reverse phase high pressure liquid chromatography. Anal Biochem 114:383-387, 1981
23. Loguercio C, Taranto D, Beneduce F, del Vecchio Blanco C, de Vincentis A, Nardi G, Romano M: Glutathione prevents ethanol induced gastric mucosal damage and depletion of sulfhydryl compounds in humans. Gut 34(2): 161-165, 1993
24. Esterbauer H, Cheeseman KH: Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186:407-421, 1990
25. Dunn MA, Blalock TL, Cousins RY: Metallothionein. Proc Soc Exp Biol Med 185:107-119, 1987
26. Grisham MB, McCord JM: Chemistry and cytotoxicity of reactive oxygen metabolites. In A Taylor, S Matalon, PA Ward (eds). Physiology of Oxygen Radicals. Bethesda, Maryland, American Physiological Society, 1986, pp 1-18
27. Janero DR: Malonaldehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 9:515-540, 1990
28. Keshavarzian A, Sedghi S, Kanofsky J, List T, Robinson C, Ibrahim C, Winship D: Excessive production of reactive oxygen metabolites by inflamed colon: Analysis by chemiluminescence probe. Gastroenterology 103:177-185, 1992
29. Simmonds NJ, Allen RE, Stevens TR, Van Someren RNM, Blake DR, Rampton DS: Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology 103:186-196, 1992
30. Ahnfelt-Ronne I, Nielsen OH, Christensen A, Langholz E, Riis P: Clinical evidence supporting the radical scavenger mechanism of 5-Aminosalicylic acid. Gastroenterology 98:1162-1169, 1990
31. Dallegri F, Ottonello L, Ballestrero A, Bogliolo F, Ferrando F, Patrone F: Cytoprotection against neutrophil derived hypochlorous acid: A potential mechanism for the therapeutic action of 5-aminosalicylic acid in ulcerative colitis. Gut 31:184-186, 1990
32. Reynolds PD, Rhenius ST, Hunter JO: The source of superoxide anion in ulcerative colitis is not xanthine oxidase. 3rd UEGW Oslo A116:1354, 1994
33. Beutler E: Nutritional and metabolic aspects of glutathione. Annu Rev Nutr 9:287-302, 1989
34. Ramakrishna RDN, Harman L, Motten A, Schreiber J, Mason RP: Generation of radical anions of nitrofurantoin, misonidazole, and metronidazole by ascorbate. Arch Biochem Biophys 255:419-427, 1987